97 related articles for article (PubMed ID: 3466689)
21. Comparison of growth inhibiting effect of natural and recombinant interferon-alpha on human osteosarcomas in nude mice.
Bauer HC; Brosjö O; Strander H
J Interferon Res; 1987 Aug; 7(4):365-9. PubMed ID: 3478420
[TBL] [Abstract][Full Text] [Related]
22. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
23. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
Green DW; Roh H; Pippin JA; Drebin JA
J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein.
Liang ZH; Wu PH; Li L; Xue G; Zeng YX; Huang WL
Chin Med J (Engl); 2004 Dec; 117(12):1809-14. PubMed ID: 15603709
[TBL] [Abstract][Full Text] [Related]
25. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of human melanoma growth by prostaglandin A, D, and J analogues.
Bregman MD; Funk C; Fukushima M
Cancer Res; 1986 Jun; 46(6):2740-4. PubMed ID: 3698005
[TBL] [Abstract][Full Text] [Related]
27. Effect of interferon-alpha (IFN alpha) on various human tumor xenografts.
Nagy P; Kopper L; Gyapay G; Péterfy F; Lapis K
Anticancer Res; 1988; 8(3):467-9. PubMed ID: 3389749
[TBL] [Abstract][Full Text] [Related]
28. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
[TBL] [Abstract][Full Text] [Related]
29. Effect of human lymphoblastoid interferon on human yolk sac tumors in nude mice.
Sawada M; Matsui Y; Okudaira Y
Biken J; 1983 Dec; 26(4):169-73. PubMed ID: 6204635
[TBL] [Abstract][Full Text] [Related]
30. Antitumor effects of interferon-omega: in vivo therapy of human tumor xenografts in nude mice.
Horton HM; Hernandez P; Parker SE; Barnhart KM
Cancer Res; 1999 Aug; 59(16):4064-8. PubMed ID: 10463608
[TBL] [Abstract][Full Text] [Related]
31. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
[TBL] [Abstract][Full Text] [Related]
32. Interferon gamma is highly effective against orthotopically-implanted human pleural adenocarcinoma in nude mice.
An Z; Wang X; Astoul P; Danays T; Moossa AR; Hoffman RM
Anticancer Res; 1996; 16(5A):2545-51. PubMed ID: 8917349
[TBL] [Abstract][Full Text] [Related]
33. Antitumor effect of recombinant human interferon alpha A/D on Meth-A sarcoma in mice.
Yoshie O; Aso H; Nanjo M; Tamura K; Ebina T; Ishida N
Jpn J Cancer Res; 1986 Apr; 77(4):413-8. PubMed ID: 3084432
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
35. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
Plonowski A; Schally AV; Nagy A; Sun B; Szepeshazi K
Cancer Res; 1999 Apr; 59(8):1947-53. PubMed ID: 10213505
[TBL] [Abstract][Full Text] [Related]
37. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon.
Greiner JW; Ullmann CD; Nieroda C; Qi CF; Eggensperger D; Shimada S; Steinberg SM; Schlom J
Cancer Res; 1993 Feb; 53(3):600-8. PubMed ID: 8425194
[TBL] [Abstract][Full Text] [Related]
38. Interferon and retinoic acid suppress the growth of human papillomavirus type 16 immortalized cervical epithelial cells, but only interferon suppresses the level of the human papillomavirus transforming oncogenes.
Agarwal C; Hembree JR; Rorke EA; Eckert RL
Cancer Res; 1994 Apr; 54(8):2108-12. PubMed ID: 8174114
[TBL] [Abstract][Full Text] [Related]
39. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effect and condition of pegylated interferon alpha with paclitaxel on glioblastoma.
Son MJ; Song HS; Kim MH; Kim JT; Kang CM; Jeon JW; Park SY; Kim YJ; Groves MD; Park K; Kim JH; Nam DH
Int J Oncol; 2006 Jun; 28(6):1385-92. PubMed ID: 16685440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
